Increased ADMA levels suggest impaired nitric oxide metabolism in ankylosing spondylitis (AS) patients.Anti-TNF-α treatments showed beneficial effects on vascular function.No difference in ET-1 levels between AS patients and controls. This evidence concerns the gene TNF and ankylosing spondylitis.